The reiteration of the 'Outperform' rating by Wedbush analyst David Nierengarten indicates a positive outlook for argenx. The maintained price target of $570 suggests that the analyst believes the stock has significant upside potential. This could lead to increased investor confidence and potentially a short-term increase in the stock price.